novo integrated sciences, inc., together with its subsidiaries, provides primary healthcare services. it offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-ptsd, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. the company also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions. in addition, it offers specialty treatment and recovery program
Company profile
Ticker
NVOS
Exchange
Website
CEO
Robert Mattacchione
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
TURBINE TRUCK ENGINES INC
SEC CIK
Corporate docs
Subsidiaries
Novo Healthnet Limited • Novomerica Health Group, Inc. • PRO-DIP, LLC • Acenzia, Inc. • Terragenx Inc. • Clinical Consultants International LLC • Novo Healthnet Rehab Limited • Novo Assessments Inc. • Novo Healthnet Kemptville Centre, Inc. • 12858461 Canada Corp. ...
NVOS stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
15 Apr 24
8-K
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
15 Apr 24
8-K
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
11 Apr 24
8-K
Unregistered Sales of Equity Securities
10 Apr 24
8-K
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
26 Mar 24
8-K
Entry into a Material Definitive Agreement
19 Mar 24
8-K
Entry into a Material Definitive Agreement
18 Mar 24
8-K
Regulation FD Disclosure
21 Feb 24
8-K
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
20 Feb 24
8-K
Novo Integrated Sciences Appoints New President
16 Feb 24
Latest ownership filings
SC 13G/A
Hudson Bay Capital Management LP
6 Feb 24
4
Christopher Mehlin David
2 Jun 23
SC 13G/A
Hudson Bay Capital Management LP
10 Feb 23
4
Sarfaraz Ali
10 Aug 22
3
Sarfaraz Ali
10 Aug 22
4
Robert Letterio Oliva
21 Apr 22
4
Robert Letterio Oliva
24 Feb 22
4
Alex Flesias
24 Feb 22
4
Michael Ross Pope
24 Feb 22
SC 13G
Hudson Bay Capital Management LP
8 Feb 22
Financial summary
Quarter (USD) | Aug 23 | May 23 | Feb 23 | Nov 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Aug 23 | Aug 22 | Aug 21 | Aug 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 416.32 k | 416.32 k | 416.32 k | 416.32 k | 416.32 k | 416.32 k |
Cash burn (monthly) | 15.90 k | 146.86 k | 1.07 mm | 1.11 mm | 76.26 k | 186.94 k |
Cash used (since last report) | 121.29 k | 1.12 mm | 8.14 mm | 8.44 mm | 581.88 k | 1.43 mm |
Cash remaining | 295.03 k | -704.32 k | -7.73 mm | -8.02 mm | -165.56 k | -1.01 mm |
Runway (months of cash) | 18.6 | -4.8 | -7.2 | -7.3 | -2.2 | -5.4 |
Institutional ownership, Q2 2023
12.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 10 |
Closed positions | 3 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 290.07 mm |
Total shares | 2.19 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Geode Capital Management | 816.60 k | $120.94 mm |
STT State Street | 290.19 k | $42.98 mm |
Vanguard | 238.86 k | $35.38 mm |
VIRT Virtu Financial | 233.48 k | $35.00 k |
UBS UBS Group AG - Registered Shares | 138.14 k | $20.45 mm |
Cubist Systematic Strategies | 130.13 k | $19.27 mm |
NTRS Northern Trust | 88.89 k | $13.17 mm |
RY Royal Bank Of Canada | 76.39 k | $11.00 mm |
Two Sigma Securities | 64.48 k | $9.55 mm |
Axxcess Wealth Management | 55.00 k | $8.15 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 May 23 | Christopher Mehlin David | Stock Option Common Stock | Grant | Acquire A | No | No | 0.132 | 2,000,000 | 264.00 k | 2,000,000 |
News
Novo Integrated Sciences Q2 EPS $(0.16) Up From $(0.59) YoY, Sales $3.17M Up From $2.56M YoY
15 Apr 24
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
11 Apr 24
12 Health Care Stocks Moving In Tuesday's After-Market Session
9 Apr 24
12 Health Care Stocks Moving In Monday's Pre-Market Session
8 Apr 24
12 Health Care Stocks Moving In Thursday's Pre-Market Session
4 Apr 24
Press releases
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
15 Apr 24
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
11 Apr 24
CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA
11 Apr 24
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
26 Mar 24
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
20 Feb 24